cortexolone 17α-propionate
Sponsors
Intrepid Therapeutics, Inc., Cassiopea SpA
Conditions
Acne Vulgaris
Phase 2
An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris
CompletedNCT01831960
Start: 2013-04-30End: 2013-11-30Updated: 2020-12-02
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
CompletedNCT02720627
Start: 2016-10-28End: 2018-03-21Updated: 2020-11-20